Naloxone for narcotic exposed newborn infants: Systematic review

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 4, 2003, Pages

  McGuire, W ^a   Fowlie, P W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE; OPIATE ANTAGONIST; PLACEBO;

ASSISTED VENTILATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; EMBASE; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; LUNG VENTILATION; MEDLINE; NEWBORN; OUTCOMES RESEARCH; PLACENTAL TRANSFER; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; REVIEW; SIDE EFFECT; STANDARD;

EID: 0038051545     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.88.4.f308     Document Type: Review

References (17)

1. Niermeyer S, Van Reempts P, Kattwinkel J, et al. Resuscitation of newborns. Ann Emerg Med 2001;37:S110-25.
2. American Academy of Pediatrics Committee on Drugs. Naloxone use in newborns. Pediatrics 1980;65:667-9.
3. American Academy of Pediatrics Committee on Drugs. Naloxone dosage and route of administration for infants and children: addendum to emergency drug doses for infants and children. Pediatrics 1990;86:484-5.
4. Herschel M, Khoshnood B, Lass NA. Role of naloxone in newborn resuscitation. Pediatrics 2000;106:831-4.
5. Smotherman WP, Robinson SR. Prenatal experience with milk: fetal behavior and endogenous opioid systems. Neurosci Biobehav Rev 1992;16:351-64.
6. de Castro RM, Cabral-Filho JE, Costa JA, et al. Neonatal treatment with naloxone causes permanent hyperalgesia in rats. Braz J Med Biol Res 1993;26:747-51.
7. Szeto HH, Soong Y, Wu DL, et al. Opioid modulation of fetal glucose homeostasis: role of receptor subtypes. J Pharmacol Exp Ther 1995;275:334-9.
8. Bonta BW, Gagliardi JV, Williams V, et al. Naloxone reversal of mild neurobehavioral depression in normal newborn infants after routine obstetric analgesia. J Pediatr 1979;94:102-5.
9. Brice JE, Moreland TA, Walker CH. Effects of pethidine and its antagonists on the newborn. Arch Dis Child 1979;54:356-61.
10. Dick W, Knoche E, Traub E. Clinical investigations of the influence of various naloxone doses on the newborn. J Perinat Med 1978;6:95-101.
11. Evans JM, Hogg MI, Rosen M. Reversal of narcotic depression in the neonate by naloxone. BMJ 1976;2:1098-100.
12. Gerhardt T, Bancalari E, Cohen H, et al. Use of naloxone to reverse narcotic respiratory depression in the newborn. J Pediatr 1977;90:1009-12.
13. Welles B, Belfrage P, de Chateau P. Effects of naloxone on newborn infant behavior after maternal analgesia with pethidine during labor. Acta Obstet Gynecol Scand 1984;63:617-19.
14. Wiener PC, Hogg MI, Rosen M. Effects of naloxone on pethidine-induced neonatal depression. Part 1. Intravenous naloxone. BMJ 1977;2:228-9.
15. Wiener PC, Hogg MI, Rosen M. Effects of naloxone on pethidine-induced neonatal depression. Part 2. Intramuscular naloxone. BMJ 1977;2:229-31.
16. Weiner PC, Hogg MI, Rosen M. Neonatal respiration, feeding and neurobehavioural state. Effects of intrapartum bupivacaine, pethidine and pethidine reversed by naloxone. Anaesthesia 1979;34:996-1004.
17. Brice JEH, Moreland TA, Parija AC, et al. Plasma naloxone levels in the newborn after intravenous or intramuscular administration. Br J Clin Pharmacol 1979;8:412P-13P.